Skip to content
XPR
content.
Press releases
Video
Podcasts
Op-eds
Lists
Guest posts
Author:
enVVeno Medical Corporation
enVVeno Medical Reports Second Quarter 2026 Financial Results and Advances Towards FDA Pivotal Trial for First-in-Class Non-Surgical Replacement Venous Valve
July 31, 2026
enVVeno Medical Highlights Newly Issued U.S. Patent Strengthening Competitive Position Ahead of Historic Pivotal Trial in Virtual Investor “What This Means” Segment
July 15, 2026
enVVeno Medical Secures Transformational U.S. Patent for enVVe System, Strengthening Competitive Moat Ahead of Launch of Historic FDA Pivotal Trial
July 7, 2026
enVVeno Medical to Present in the Webull Corporate Connect Webinar Series
June 22, 2026
enVVeno Medical to Participate in the Virtual Investor Closing Bell Series
June 2, 2026